KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesR&D In ProcessReceivables - NetReceivables - Other
Ratios

Eli Lilly (LLY) Long-Term Debt Issuances (2016 - 2025)

Eli Lilly's Long-Term Debt Issuances history spans 12 years, with the latest figure at -$200000.0 for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances fell 100.0% year-over-year to -$200000.0; the TTM value through Dec 2025 reached $13.2 billion, up 15.33%, while the annual FY2025 figure was $13.2 billion, 15.33% up from the prior year.
  • Long-Term Debt Issuances reached -$200000.0 in Q4 2025 per LLY's latest filing, down from $6.7 billion in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $6.7 billion in Q3 2025 to a low of -$200000.0 in Q4 2025.
  • Average Long-Term Debt Issuances over 4 years is $3.4 billion, with a median of $4.0 billion recorded in 2023.
  • Peak YoY movement for Long-Term Debt Issuances: surged 124.53% in 2021, then tumbled 120.0% in 2024.
  • A 4-year view of Long-Term Debt Issuances shows it stood at $2.4 billion in 2021, then crashed by 99.98% to $500000.0 in 2023, then tumbled by 120.0% to -$100000.0 in 2024, then plummeted by 100.0% to -$200000.0 in 2025.
  • Per Business Quant, the three most recent readings for LLY's Long-Term Debt Issuances are -$200000.0 (Q4 2025), $6.7 billion (Q3 2025), and $6.5 billion (Q1 2025).